Compare NPKI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPKI | QSI |
|---|---|---|
| Founded | 1932 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 184.2M |
| IPO Year | N/A | N/A |
| Metric | NPKI | QSI |
|---|---|---|
| Price | $14.40 | $0.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $14.17 | $1.00 |
| AVG Volume (30 Days) | 747.6K | ★ 2.9M |
| Earning Date | 04-30-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.17 | N/A |
| Revenue Next Year | $13.22 | $618.07 |
| P/E Ratio | $38.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.76 | $0.79 |
| 52 Week High | $15.85 | $3.10 |
| Indicator | NPKI | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 36.30 |
| Support Level | $13.31 | N/A |
| Resistance Level | $14.87 | $1.11 |
| Average True Range (ATR) | 0.49 | 0.06 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 68.24 | 5.45 |
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.